GL1X · GenesisL1 explorer

Research workbench

Crystal structure of type VI effector TSE1 from pseudomonas aeruginosa

Analyse Crystal structure of type VI effector TSE1 from pseudomonas aeruginosa in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3VPI
Type
protein
Length
152 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Type VI secretion exported 1
UniProt
Q9I2Q1
Pockets
1 · best druggability 0.28

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AType VI secretion exported 1protein15235% helix, 20% strandQ9I2Q1

Ligands and binding sites

  • FMT · Formic acid · additive · 9 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1550.280.7415empty

Modifications

Observed in the structure: 3 modified (engineered).

Compared structures

  • 3VPI · Crystal structure of type VI effector Tse1 from Pseudomonas aeruginosa · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9I2Q1 · AlphaFold monomer V2.0 prediction for peptidoglycan amidase TSE1 (Q9I2Q1) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.